In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Health and biology company Verily Life Sciences receives $800mm investment from Temasek

Executive Summary

Verily Life Sciences LLC (research and engineering company focusing on improving health outcomes) received an $800mm investment from Singapore investment company Temasek in exchange for a minority stake in the company (also appoints one director to company's board). The two companies will also collaborate on expanding Verily's programs outside of the US.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
    • Glucose Testing
  • Biotechnology
    • Nanotechnology, Chips, etc.
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register